Position in CTMX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$420,570
-$713,140 QoQ
Shares Held
112,152
-53.5% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#74
of 178 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in CTMX Over Time
Shares Held
Position Value (USD)
Derivatives in CTMX
reported options exposure · as of Sep 30, 2024CallValue
$128,620
CallShares
109,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Squarepoint Ops LLC holds $1,234,876,212 across 255 Biotechnology names. CTMX ranks #161 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
198,567 | $123,814,467 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
1,191,732 | $88,760,199 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,999 | $70,440,718 | |
| 4 | INSM |
INSMED Inc
|
616,464 | $65,727,391 | |
| 5 | ARGX |
Argenx SE
|
58,400 | $54,181,768 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
422,921 | $46,956,918 | |
| 7 | APGE |
Apogee Therapeutics, Inc.
|
290,713 | $38,586,336 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
154,605 | $37,842,665 |
All Filings in CTMX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $420,570 | 112,152 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,133,710 | 241,215 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $212,561 | 49,897 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $152,252 | 47,728 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $112,119 | 49,392 | Shares | Defined | 2025-08-27 | |
| 2024-09-30 | $128,620 | 109,000 | Call | Defined | 2024-11-14 | |
| 2024-06-30 | $242,584 | 198,840 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $102,460 | 47,000 | Call | Defined | 2024-05-15 | |
| 2024-03-31 | $458,129 | 210,151 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $233,326 | 150,533 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $223,976 | 173,625 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $317,329 | 184,494 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $73,772 | 48,856 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $15,258 | 10,523 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $85,429 | 46,683 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $285,051 | 106,761 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $164,319 | 37,949 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $202,164 | 39,718 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,736,656 | 748,287 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $631,641 | 81,713 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $503,092 | 76,808 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $257,640 | 38,743 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $963,481 | 115,664 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $93,504 | 12,191 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||